bortezomib fresenius kabi 3.5 mg
neopharm (israel) 1996 ltd - bortezomib - powder for solution for injection - bortezomib 3.5 mg/vial - bortezomib - multiple myelomabortezomib fresenius kabi is indicated for the treatment of adult patients with multiple myeloma.mantle cell lymphomabortezomib fresenius kabi for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib fresenius kabi in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
bortezomib 3.5 mg powder for solution for injection
reddy holding gmbh - bortezomib - powder for solution for injection - bortezomib
bortezomib 2.5 mg powder for solution for injection
morningside healthcare (malta) limited - bortezomib - powder for solution for injection - bortezomib
bortezomib biotech pharma 3.5 mg powder for solution for injection
target healthcare limited - bortezomib - powder for solution for injection - bortezomib
bortezomib waverley 3.5 mg powder for solution for injection
waverley pharma europe limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 1 mg powder for solution for injection
aspire pharma limited - bortezomib - powder for solution for injection - 1 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 3.5 mg powder for solution for injection
aspire pharma limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib medac 3.5 mg powder for solution for injection
medac gesellschaft für klinische spezialpräparate mbh - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 1 mg powder for solution for injection
european regulatory affairs t/a ivowen - bortezomib - powder for solution for injection - 1 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 3.5 mg powder for solution for injection
european regulatory affairs t/a ivowen - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib